FDA Adverse Event Injury Summary report: N

ACRYSOF

MDR report key: 2231178 · Received August 26, 2011

Report

Report Number
1119421-2011-01049
Event Type
Injury
Date Received
August 26, 2011
Date of Event
July 28, 2011
Report Date
July 29, 2011
Manufacturer
ALCON RESEARCH, LTD. / HUNTINGTON
Product Code
HQL
PMA / PMN Number
P930014
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PRODUCT EVALUATION: THE PRODUCT WAS NOT RETURNED FOR ANALYSIS. RESULTS FROM THE PRODUCT HISTORY RECORD REVIEW INDICATED THE PRODUCT MET RELEASE CRITERIA. ROOT CAUSE: THE ROOT CAUSE COULD NOT BE DETERMINED FROM THE INVESTIGATION. ACTION TAKEN: INVESTIGATION HAS BEEN COMPLETED BASED ON CURRENT INFORMATION. NO FURTHER ACTION IS WARRANTED AT THIS TIME. CONCLUSION: BASED ON OUR CURRENT TRACKING, THERE ARE NO ADVERSE TRENDS FOR THIS REPORTED COMPLAINT AND BASED ON THESE FINDINGS THE RESIDUAL RISK REMAINS UNCHANGED AND AT AN ACCEPTABLE LEVEL. THERE HAVE BEEN NO OTHER COMPLAINTS REPORTED IN THE LOT NUMBER. ADDITIONAL INFORMATION HAS BEEN REQUESTED. (B)(4).

Description of Event or Problem · 1

A STUDY COORDINATOR REPORTED A STUDY PATIENT WITH BLURRED VISION, DISTORTION AND DOUBLE VISION FOLLOWING BILATERAL INTRAOCULAR LENS (IOL) IMPLANT SURGERIES. THE SURGEON REPORTED THAT THESE EVENTS ARE NOT RELATED TO THE STUDY DEVICE, BUT A RESIDUAL REFRACTIVE ERROR AFTER SURGERY. THE SURGEON ALSO REPORTED THE PATIENT EXPERIENCED A CHANGE IN BRIGHTNESS FOLLOWING THE PROCEDURE. THIS EVENT IS NOT RELATED TO THE STUDY DEVICE, BUT IS CAUSED BY READING GLASSES THAT BLOCK THE LIGHT. ADDITIONAL INFORMATION HAS BEEN REQUESTED. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THESE EVENTS; THIS REPORT IS FOR THE RIGHT EYE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACRYSOF INTRAOCULAR LENS HQL ALCON RESEARCH, LTD. / HUNTINGTON SN60WF 12031381

Patients

Seq Age Sex Outcome Treatment
1 75 YR Other XALATAN| ETODOLAC| LOSARTAN| PRAMIPEXOL| BABY ASPIRIN| FUROSEMIDE| SKELAXIN| LIPITOR| TIMOLOL